Pfizer To Submit Covid Pill Data To FDA

FILE - The Pfizer logo is displayed at the company's headquarters in New York, on Feb. 5, 2021. In a statement on Tuesday, Nov. 16, 2021, drugmaker Pfizer Inc. said it has signed a deal with a U.N.-backed group to allow other manufacturers to make its experimental coronavirus pill, in a move that could make its treatment available to more than half of the world’s population. (AP Photo/Mark Lennihan, File)

Pfizer says its COVID treatment pill is having terrific initial results. The company will submit its full data on pill to the FDA soon. CEO Albert Bourla says the results show that the pill reduces risk of hospitalization and death by 89 percent. Bourla told CNBC that he’s confident the data will be true to what Pfizer saw in initial studies.  The antiviral pill would be available for the public to purchase this month is the FDA approves it.

Biden Talks About Warning Putin Over Ukraine

Previous article

US Businesses Advertised Near-Record 11 Million Open Jobs

Next article

You may also like